Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce

Jefferies Reiterates Buy on Allscripts (MDRX) Following 4Q

February 17, 2017 8:26 AM EST

Jefferies reiterated a Buy rating and $16.50 price target on Allscripts (NASDAQ: MDRX) following 4Q earnings report. MDRX reported EPS of $0.14, which compares to $0.15 for consensus. Downside was driven by higher SG&A, partially offset by better revenue, a higher gross margin and... More

Allscripts (MDRX) PT Raised to $13 at Cantor Fitzgerald Following In-Line 4Q Results

February 17, 2017 7:22 AM EST

Cantor Fitzgerald analyst Steven Halper reiterates Neutral rating and raises price target on Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) to $13 (from $12), suggesting shares remain fairly valued, as the company reported 2016 fourth quarter results in-line with estimates, while 2017 guidance was also in-line with... More